{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:32:52Z","timestamp":1789173172042,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T00:00:00Z","timestamp":1413936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.cardfail.2014.10.001","type":"journal-article","created":{"date-parts":[[2014,10,13]],"date-time":"2014-10-13T11:15:18Z","timestamp":1413198918000},"page":"953-958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":150,"title":["Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl"],"prefix":"10.1016","volume":"20","author":[{"given":"Melanie P.","family":"Chin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Wrolstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George L.","family":"Bakris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn M.","family":"Chertow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick","family":"de Zeeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angie","family":"Goldsberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Linde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6317-3975","authenticated-orcid":false,"given":"John J.","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Wittes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin J.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2014.10.001_bib1","doi-asserted-by":"crossref","first-page":"F1180","DOI":"10.1152\/ajprenal.00353.2010","article-title":"Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPAR\u03b3, and HO-1","volume":"300","author":"Wu","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cardfail.2014.10.001_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.molcel.2009.07.025","article-title":"KEAP1 E3 ligase\u2013mediated downregulation of NF-kappaB signaling by targeting IKKbeta","volume":"36","author":"Lee","year":"2009","journal-title":"Mol Cell"},{"key":"10.1016\/j.cardfail.2014.10.001_bib3","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1073\/pnas.0500815102","article-title":"Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress","volume":"102","author":"Dinkova-Kostova","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cardfail.2014.10.001_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mrrev.2007.11.006","article-title":"Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults","volume":"659","author":"Osburn","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.cardfail.2014.10.001_bib5","doi-asserted-by":"crossref","first-page":"F1438","DOI":"10.1152\/ajprenal.00387.2012","article-title":"Bardoxolone methyl analogs RTA 405 and dh404 are well tolerated and exhibit efficacy in rodent models of Type 2 diabetes and obesity","volume":"304","author":"Chin","year":"2013","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.cardfail.2014.10.001_bib6","unstructured":"Ma R, Bumeister R, Stidham R. Bardoxolone methyl (BARD) inhibits inflammatory signaling in cultured mesangial cells. Proceedings of the National Kidney Foundation Spring Clinical Meetings, April 13-17, 2010, Lake Buena Vista, FL."},{"key":"10.1016\/j.cardfail.2014.10.001_bib7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/ki.2012.393","article-title":"The synthetic triterpenoid, RTA 405, increases the glomerular filtration rate and reduces angiotensin II-induced contraction of glomerular mesangial cells","volume":"83","author":"Ding","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.cardfail.2014.10.001_bib8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3109\/00498254.2013.852705","article-title":"The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease","volume":"44","author":"Aminzadeh","year":"2014","journal-title":"Xenobiotica"},{"key":"10.1016\/j.cardfail.2014.10.001_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1105351","article-title":"Bardoxolone methyl and kidney function in CKD with type 2 diabetes","volume":"365","author":"Pergola","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2014.10.001_bib10","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"de Zeeuw","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2014.10.001_bib11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000346948","article-title":"Rationale and trial design of Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON)","volume":"37","author":"de Zeeuw","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.cardfail.2014.10.001_bib12","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/ndt\/gft445","article-title":"Baseline characteristics in the Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus: The Occurrence of Renal Events (BEACON) trial","volume":"28","author":"Lambers Heerspink","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cardfail.2014.10.001_bib13","series-title":"Classification and regression trees","first-page":"368","author":"Breiman","year":"1984"},{"key":"10.1016\/j.cardfail.2014.10.001_bib14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1681\/ASN.2009060593","article-title":"Avosentan for overt diabetic nephropathy","volume":"21","author":"Mann","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cardfail.2014.10.001_bib15","first-page":"ii403","article-title":"Exposure-response analyses of bardoxolone methyl safety and efficacy and clinical trial simulations to inform phase III dose selection","volume":"27","author":"Klein","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cardfail.2014.10.001_bib16","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1532-5415.1990.tb03450.x","article-title":"Early readmission of elderly patients with congestive heart failure","volume":"38","author":"Vinson","year":"1990","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.cardfail.2014.10.001_bib17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.CIR.0000025242.79963.4C","article-title":"B-Type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) multinational study","volume":"106","author":"McCullough","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.10.001_bib18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(03)13976-1","article-title":"B-Type natriuretic peptide in cardiovascular disease","volume":"362","author":"De Lemos","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2014.10.001_bib19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1159\/000362906","article-title":"Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl","volume":"39","author":"Chin","year":"2014","journal-title":"Am J Nephrol"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107191641401224X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107191641401224X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:41:35Z","timestamp":1761028895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107191641401224X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S107191641401224X"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2014.10.001","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2014.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}